{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Cardinal Health, Inc.
Cardinal Health, Inc. Hits New 52-Week High of $195.15
Cardinal Health, Inc. achieved a new 52-week high of USD 195.15 on October 30, 2025, reflecting a 92.07% stock appreciation over the past year. With a market capitalization of USD 42,348 million, the company faces challenges in profitability, as indicated by its negative return on equity and price-to-book ratio.
Cardinal Health, Inc. Sees Revision in Stock Evaluation Amid Strong Market Performance
Cardinal Health, Inc. has recently revised its evaluation, with its stock price rising to $163.80. Over the past year, the company has achieved a return of 46.04%, significantly outperforming the S&P 500. The stock shows a generally positive technical outlook, despite some mixed short-term signals.
Is Cardinal Health, Inc. technically bullish or bearish?
As of October 24, 2025, Cardinal Health, Inc. shows a bullish trend with moderate strength, supported by positive signals from moving averages and OBV, despite mixed MACD and KST indicators, and has significantly outperformed the S&P 500 with a year-to-date return of 36.88%.
Is Cardinal Health, Inc. technically bullish or bearish?
As of October 24, 2025, Cardinal Health, Inc. is in a bullish trend supported by moving averages and Bollinger Bands, despite a mildly bearish MACD signal, with year-to-date and one-year returns significantly outperforming the S&P 500.
Is Cardinal Health, Inc. technically bullish or bearish?
As of October 24, 2025, Cardinal Health, Inc. shows a bullish technical trend with strong daily moving averages and positive year-to-date and one-year returns, despite some mixed signals from weekly indicators.
Cardinal Health Experiences Revision in Stock Evaluation Amid Strong Market Performance
Cardinal Health, Inc. has recently revised its evaluation amid changing market conditions. The stock is currently priced at $154.31, reflecting a slight decrease from the previous close. Over the past year, the company has achieved a 37.15% return, significantly outperforming the S&P 500's 13.36%.
Is Cardinal Health, Inc. technically bullish or bearish?
As of October 10, 2025, Cardinal Health, Inc. has a mildly bullish technical trend, supported by daily moving averages and a bullish monthly MACD, despite mixed signals from the weekly MACD and Dow Theory, while outperforming the S&P 500 with year-to-date and one-year returns of 32.65% and 37.81%, respectively.
Cardinal Health Stock Hits Day High with Strong Intraday Performance
Cardinal Health, Inc. has seen significant stock performance improvements, with notable gains over various time frames. The company has outperformed the S&P 500 recently, showcasing impressive annual growth. However, it faces challenges such as a negative book value and weak long-term fundamentals, indicating a complex market position.
Is Cardinal Health, Inc. technically bullish or bearish?
As of July 24, 2025, Cardinal Health, Inc. shows a mildly bullish trend with mixed technical indicators, having outperformed the S&P 500 year-to-date and over one year, but underperformed over the last decade.
Is Cardinal Health, Inc. overvalued or undervalued?
As of May 5, 2022, Cardinal Health, Inc. is considered risky due to its high P/E ratio of 27, negative price-to-book value of -14.78, and elevated EV to EBITDA ratio of 15.20, despite a low PEG ratio of 0.23 and a recent 34.67% return outperforming the S&P 500.
Is Cardinal Health, Inc. technically bullish or bearish?
As of April 24, 2025, Cardinal Health, Inc. shows a bullish technical trend supported by positive weekly and daily indicators, though caution is advised due to a bearish monthly RSI.
Is Cardinal Health, Inc. overvalued or undervalued?
As of May 5, 2022, Cardinal Health, Inc. is considered overvalued with a risky valuation grade, reflected in its P/E ratio of 27 and strong stock performance of 38.66% year-to-date, despite lower PEG and higher ratios compared to peers like McKesson and Boston Scientific.
Who are in the management team of Cardinal Health, Inc.?
As of March 2022, Cardinal Health, Inc.'s management team includes CEO Michael Kaufmann and Independent Non-Executive Chairman Gregory Kenny, along with several Independent Directors: Carrie Cox, Calvin Darden, Bruce Downey, and Sheri Edison.
What does Cardinal Health, Inc. do?
Cardinal Health, Inc. is a healthcare services and products company with a market cap of approximately $46.45 billion, reporting net sales of $54.88 billion and a net profit of $508 million for Q1 2025. Key metrics include a P/E ratio of 27.00 and a return on equity of -55.76%.
How big is Cardinal Health, Inc.?
As of Jun 24, Cardinal Health, Inc. has a market capitalization of $46.45 billion, with net sales of $222.29 billion and a net profit of $1.56 billion for the latest four quarters. Shareholder's funds are reported at -$3.21 billion, while total assets amount to $45.12 billion.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
